Tebano, G.; Zaghi, I.; Baldasso, F.; Calgarini, C.; Capozzi, R.; Salvadori, C.; Cricca, M.; Cristini, F.
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician? Pathogens 2024, 13, 88.
https://doi.org/10.3390/pathogens13010088
AMA Style
Tebano G, Zaghi I, Baldasso F, Calgarini C, Capozzi R, Salvadori C, Cricca M, Cristini F.
Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician? Pathogens. 2024; 13(1):88.
https://doi.org/10.3390/pathogens13010088
Chicago/Turabian Style
Tebano, Gianpiero, Irene Zaghi, Francesco Baldasso, Chiara Calgarini, Roberta Capozzi, Caterina Salvadori, Monica Cricca, and Francesco Cristini.
2024. "Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?" Pathogens 13, no. 1: 88.
https://doi.org/10.3390/pathogens13010088
APA Style
Tebano, G., Zaghi, I., Baldasso, F., Calgarini, C., Capozzi, R., Salvadori, C., Cricca, M., & Cristini, F.
(2024). Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician? Pathogens, 13(1), 88.
https://doi.org/10.3390/pathogens13010088